CI_with has_DoseForm has_Ingredient has_MoA has_PE may_treat drug associated with AE Cellular or Molecular Interactions [MoA] Drug Hypersensitivity [Disease/Finding] Hypercholesterolemia [Disease/Finding] Hyperlipoproteinemia Type II [Disease/Finding] Decreased Cholesterol Absorption [PE] ezetimibe [Chemical/Ingredient] [CV350] ANTILIPEMIC AGENTS Oral Tablet [Dose Form] EZETIMIBE EZETIMIBE 10MG TAB [VA Product] EZETIMIBE TAB N0000164051 C40930 <Product_Component>EZETIMIBE</Product_Component><Strength>10</Strength><Unit>MG</Unit><VA.IEN>4040</VA.IEN> VA Product 0 4016366 10 349556 C1165147 ezetimibe 10 MG Oral Tablet EZETIMIBE 10MG TAB 依折麦布片（进口） EZETIMIBE 10MG TAB MG <VANDF_Record>50.68^16003^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>16003</VA_IEN><VA_Status>Active/Master</VA_Status> fatigue AE abdominal distension AE alanine aminotransferase level increased AE myalgia AE headache AE abdominal pain AE nausea AE constipation AE diarrhea AE aspartate aminotransferase level increased AE clinically significant rise of serum transaminase AE EZETIMIBE 10MG TAB [VA Product] EZETIMIBE TAB N0000164051 C40930 349556 <Product_Component>EZETIMIBE</Product_Component><Strength>10</Strength><Unit>MG</Unit><VA.IEN>4040</VA.IEN> VA Product 4016366 0 C1165147 ezetimibe 10 MG Oral Tablet EZETIMIBE 10MG TAB 依折麦布片（进口） EZETIMIBE 10MG TAB 10 MG <VANDF_Record>50.68^16003^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>16003</VA_IEN><VA_Status>Active/Master</VA_Status>